• Home
  • About Us
    • AdAlta at a glance
    • Board
    • Management Team
  • Cancer Cell Therapies
    • “East to West” strategy
    • “East to West” product pipeline
  • I-Body Therapeutics
    • i-bodies
    • AD-214: A new approach to fibrotic disease
    • Fibrosis
  • Investors
    • Annual and Financial Reports
    • Presentations
    • Analyst Reports
    • ASX Announcements
    • News & Media
    • Corporate Governance
  • Contact Us

AdAlta investor day 21 Feb 2017 presentations

AdAlta investor day 21 Feb 2017 presentations

© 2025 AdAlta Limited Disclaimer | Privacy Policy
© 2016 AdAlta Limited